Regulation of transforming growth factor-beta signaling
- PMID: 11703090
- DOI: 10.1006/mcbr.2001.0301
Regulation of transforming growth factor-beta signaling
Abstract
Members of transforming growth factor beta (TGF-beta) family are potent regulators of multiple cellular functions, including cell proliferation, differentiation, migration, organization, and death. Yet the signaling pathways underpinning a wide array of biological activities of TGF-beta appear to be deceptively simple. At every step from TGF-beta secretion to activation of its target genes, the activity of TGF-beta is regulated tightly, both positively and negatively. Biologically active TGF-beta is cleaved from a precursor protein (latent form) and multiple process factors control the levels of active TGF-beta. The efficient secretion, correct folding and deposition to the extracellular matrices require the cosecretion of latent TGF-beta binding proteins (LTBPs). Once activated, TGF-beta ligand signals through a heteromeric receptor complex of two distinct type I and type II serine/threonine kinase receptors TbetaRI and TbetaRII. Many factors appear to influence the formation of the active ligand-receptor complex. The relative orientation of TbetaRI and TbetaRII in the ligand-receptor complex is critical for activation: through TbetaRI, the activated ligand-receptor complex directly binds and phosphorylates downstream intracellular substrates, called Smads. Inhibitory Smads, Smad6 and 7, can antagonize this process. The phosphorylation of Smads leads to the formation of complexes which translocate to the nucleus. Other signaling systems can modulate the activity of the Smads: e.g., ras activity can prevent Smad complexes from entering the nucleus and specific ubiquitin ligases can target Smad for degradation. In the nucleus, the Smad complexes associate with other transcription activators or suppressors to regulate gene expression, either positively or negatively. The combined effects of the positive and/or negative TGF-beta controlled gene expression together with the endogenous protein set of the target cell are responsible for the multiplicity of biological functions.
Copyright 2001 Academic Press.
Similar articles
-
Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis.Oncogene. 2005 Aug 29;24(37):5742-50. doi: 10.1038/sj.onc.1208928. Oncogene. 2005. PMID: 16123807 Review.
-
Crossing Smads.Sci STKE. 2000 Mar 14;2000(23):re1. doi: 10.1126/stke.2000.23.re1. Sci STKE. 2000. PMID: 11752591 Review.
-
Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellular carcinoma: implications for roles of smads in its growth.Hepatology. 2000 Aug;32(2):218-27. doi: 10.1053/jhep.2000.9145. Hepatology. 2000. PMID: 10915727
-
Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.Cancer Res. 2002 May 15;62(10):2778-90. Cancer Res. 2002. PMID: 12019154
-
TGF-beta family signal transduction in Drosophila development: from Mad to Smads.Dev Biol. 1999 Jun 15;210(2):251-68. doi: 10.1006/dbio.1999.9282. Dev Biol. 1999. PMID: 10357889 Review.
Cited by
-
Regenerative and fibrotic pathways in canine hepatic portosystemic shunt and portal vein hypoplasia, new models for clinical hepatocyte growth factor treatment.Comp Hepatol. 2005 Dec 7;4:7. doi: 10.1186/1476-5926-4-7. Comp Hepatol. 2005. PMID: 16336649 Free PMC article.
-
Ras enhances TGF-β signaling by decreasing cellular protein levels of its type II receptor negative regulator SPSB1.Cell Commun Signal. 2018 Mar 13;16(1):10. doi: 10.1186/s12964-018-0223-4. Cell Commun Signal. 2018. PMID: 29534718 Free PMC article.
-
Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-β.Am J Respir Crit Care Med. 2012 Oct 15;186(8):740-51. doi: 10.1164/rccm.201201-0084OC. Epub 2012 Aug 23. Am J Respir Crit Care Med. 2012. PMID: 22923663 Free PMC article.
-
Current status and challenges of cytokine pharmacology.Br J Pharmacol. 2009 Jun;157(3):342-61. doi: 10.1111/j.1476-5381.2009.00206.x. Epub 2009 Apr 3. Br J Pharmacol. 2009. PMID: 19371342 Free PMC article. Review.
-
Schistosoma mansoni TGF-beta receptor II: role in host ligand-induced regulation of a schistosome target gene.PLoS Pathog. 2006 Jun;2(6):e54. doi: 10.1371/journal.ppat.0020054. Epub 2006 Jun 16. PLoS Pathog. 2006. PMID: 16789838 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources